Allergy & immunology
- A MYSTERY TO MASTER. Rosen, Ted; Mills, Julie M. // RN;Aug82, Vol. 45 Issue 8, p52
Offers information on the incidence of mastocytosis. Occurrence of urticana pigmentosa as manifestations of the disease; Symptoms of the disease; Physiological effect of drugs and seafoods in inducing the disease.
- Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis. Pardanani, A; Chen, D; Abdelrahman, R A; Reichard, K K; Zblewski, D; Wood, A J; McClure, R F; Butterfield, J H; Hanson, C A; Tefferi, A // Leukemia (08876924);Oct2013, Vol. 27 Issue 10, p2091
A letter to the editor is presented in response to the article related to Clonal mast cell diseases and diagnosis of mastocytosis in the August 16, 2013 issue.
- Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study. Horny, H.-P.; Greschniok, A.; Jordan, J.-H.; Menke, D.M.; Valent, P. // Journal of Clinical Pathology;Feb2003, Vol. 56 Issue 2, p103
Background: Two cell specific neutral proteases, tryptase and chymase, are produced by human mast cells (MC). Tryptase is constitutively expressed by all MC, whereas chymase is found only in an MC subset. Very little is known about chymase expression in MC proliferative disorders (mastocytosis)....
- Elevated expression of the proto-oncogene c-kit in patients with mastocytosis. Nagata, H; Worobec, A S; Semere, T; Metcalfe, D D // Leukemia (08876924);Feb98, Vol. 12 Issue 2, p175
The stem cell factor (SCF)c-kit receptor interaction plays a critical role in the development and survival of mast cells. Several studies have also associated c-kit receptor mutations with the human diseases, mastocytosis and piebaldism. Over-expression of c-kit has been reported to be...
- Mast cell tryptase and asthma. Zhang, M-Q.; Timmerman, H. // Mediators of Inflammation;Dec97, Vol. 6 Issue 5/6, p311
Recent physiological and pharmacological studies have indicated the potential importance of tryptase, the major protein component in mast cells, in inflammatory diseases (especially asthma). Being released at inflammatory sites after the activation of mast cells, tryptase is capable of causing...
- Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis. // Current Medical Literature: Dermatology;2007, Vol. 12 Issue 3, p85
An abstract of the article "Tryptase detection in bone-marrow blood: a new diagnostic tool in systematic mastocytosis," by J. Proelss, J. Wenzel and Y. Ko is presented.
- Understanding Dual-Action Medications. Onofrey, Bruce E. // Review of Optometry;3/15/2002, Vol. 139 Issue 3, p32
Examines the concept of dual-action medication. Treatment of perennial allergy; Use of a topical mast cell inhibitor; Mechanism of the mast cell inhibitors.
- Mast cells and peptide induced histamine release. Watt, A. P. // Inflammopharmacology;2002, Vol. 9 Issue 4, p421
Mast cells are a heterogeneous population of cells, widely distributed in vertebrates, especially within connective tissues and in areas interfacing the external environment. Mast cells do not circulate as mature cells, it is postulated that mast cell differentiation is not complete until it...
- Drugs for asthma: mast-cell stabilisers. // British Medical Journal (Clinical Research Edition);2/21/1981, Vol. 282 Issue 6264, p587
Focuses on the treatment for asthma. Role of mast cells in hemostatic control of the metabolism of connective tissue; Effect of degranulation of the cells; Significance of developing mast stabilizer drugs.